News

David Muir, BSc’89, PhD’94, with decades of experience in technology research and development in the private and public sectors, joins Western University as the inaugural Associate Vice-President, Innovation and Strategic Partnerships. He comes to Western from the National Research Council Canada where he served as Director, Research and Development since 2015. Previously he held various technical and managerial roles at 3M Canada.

By working with partners in Western’s Faculty of Engineering, WORLDiscoveries has helped establish a Memorandum of Understanding between key mobility technology partners EnerTech Capital, Alectra, and Linamar that will allow for research and development collaborations in the mobility sector. Mobility technology focuses on autonomous vehicles, electrification, fleet management, and connectivity and transportation logistics.

WORLDiscoveries has a history of working with a wide range of industry verticals to help overcome technical challenges and open new and exciting market opportunities. Our team is dedicated to helping both industry and inventors find the solution that could make a difference to a company and a community.

For the culmination of their work through the 10.5-month program, the 2020-21 cohort of Western Medical Innovation Fellows (MIF) have launched a startup for one of their program projects. Tenomix will help commercialize a bench-top robotic scanning device that can automate the detection of lymph nodes in resected colorectal cancer tissues. The purpose of the device is to help pathology staff shorten sample preparation time, accelerate sample throughput, achieve productivity gains, and contribute to the current standard of care with the use of fewer laboratory resources than existing manual methods.

The nascent company just received six-figure funding from FACIT, a commercialization venture firm that builds companies with entrepreneurs to accelerate oncology innovation, with a portfolio that has attracted more than $1 billion in investment to Ontario. FACIT receives support through its strategic partner, the Ontario Institute for Cancer Research (OICR), which is funded by the Government of Ontario. FACIT also runs an annual pitch competition for Ontario-based oncology innovations, and selected Tenomix as a finalist in the 2021 event.

In the midst of the global pandemic, one of the region’s busiest pediatric doctors also became one of the country’s most prolific researchers in service to a broader public good.

Dr. Doug Fraser’s work in developing state-of-art technologies in COVID-19 and traumatic brain injury research is poised to have a national and international impact – and has earned him the prestigious Vanguard Innovator of the Year award by WORLDiscoveries.

Western has recruited some of the top scientists, engineers and medical residents from across the country to be part of the seventh cohort of its Medical Innovation Fellowship (MIF) program.

Moving into its seventh year, the Western Medical Innovation Fellowship (MIF) program has recruited a group of talented clinicians, scientists and engineers to tackle some of the medical field’s most pressing challenges.

The program takes place over 10.5 months where fellows will learn about topics relevant to business and technology commercialization, prior to being immersed in clinics, where they identify market needs. They then develop and prototype solutions by working with researchers, clinicians and technology transfer offices to generate new intellectual property. Graduates of the program have become leaders in industry, research and health care and have started their own companies.

The Innovation Ambassadors Showcase: COVID-19’s Impact on the Innovation Ecosystem was a great success with hundreds of members of the Western community tuning in to hear from the distinguished lineup of panelists.

This virtual event, hosted by the Innovation Ambassadors, was designed to promote engagement with our community by showcasing Western’s research innovation and its impact on our society in a world transformed by COVID-19.

The showcase included a keynote presentation by neuroscientist and best-selling author Adrian Owen. Following the keynote there was three panel discussions with researchers, industry professionals and entrepreneurs on how they adapted to the COVID-19 pandemic and how things have changes in research, the economy and society as a whole. The audience was able to take part in a Q&A following each presentation and discussion.

Several media outlets have shared how Annexin and its Use to Treat Inflammatory Disorders, an innovation WORLDiscoveries has been working diligently to commercialize, is being used in a trial to treat critically ill COVID-19 patients with sepsis.

Sepsis is a life-threatening condition that occurs when the body’s response to an infection turns into an overwhelming inflammatory response. The inflammatory response can cause damage to organs such as the heart, liver, lungs, and even the brain. Most critically ill COVID-19 patients develop sepsis.

The Western Innovation Fellows (MIF) have won a cash prize of $5,000 by landing the runner-up position in the 2021 MSK Innovation Competition.

First launched in the spring of 2019, the MSK competition aims to cultivate innovative ideas that can be pitched to investors and promote an entrepreneurial spirit. The stage of development is not restricted for entrants and anyone on the commercialization path is welcome to participate. The competition is open to all London-based entrepreneurial musculoskeletal experts. The initiative is hosted by the Bone and Joint Institute and the Morrissette Institute for Entrepreneurship at Western.

The Western Medical Innovation Fellows continue their winning streak having won the Best of Show prize at the 2021 Walleye Tank pitch competition. Walleye Tank is Minnesota’s life science pitch competition providing an educational and promotional opportunity for emerging medical and life science companies. 

The fellows participated in the Junior Anglers division, which is for entrepreneurs in the early stages of business development. Participants in this division have typically not incorporated their company yet or completed their minimum viable product (MVP). They competed against five other teams.